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Article / Clinical Case Report
ABSTRACT
Lymphoepithelial-like carcinoma (LEC) is a rare malignant neoplasm, which can be associated with Epstein-Barr virus (EBV) 
infection. Histologically, LEC is an undifferentiated carcinoma with an intermixed reactive lymphoplasmacytic infiltrate. 
LEC appears to be an uncommon tumor type of lip carcinoma. An 82-year-old white woman presented a lesion on her lower 
lip that developed over the last year. The lesion was characterized by ulceration with flat edges, hardened base, painful, 
and absence of regional lymphadenopathy. Microscopical analysis evidenced an intense inflammatory infiltrate, composed 
of lymphoplasmacytic cells, associated with scarce pleomorphic epithelial cells. Immunohistochemistry highlighted the LEC 
cells with strong expression of pan-CK AE1/AE3, EMA, p63, and p53. CD138 was also faintly positive. Ki-67 was >85%. 
In situ hybridization analysis did not show evidence of EBV. A diagnostic of EBV-negative LEC was made. We present an 
uncommon type of lip carcinoma, which can represent a diagnostic challenge for clinicians and pathologists. 
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INTRODUCTION
Lymphoepithelial-like carcinoma (LEC) is a 
well-recognized undifferentiated carcinoma subtype in 
the nasopharynx quite often related to Epstein-Barr virus 
(EBV) infection.1-3 The World Health Organization (WHO) 
has defined it as “a poorly differentiated squamous 
cell carcinoma (SCC) or histologically undifferentiated 
carcinoma accompanied by a prominent reactive 
lymphoplasmacytic infiltrate, morphologically similar 
to nasopharyngeal carcinoma”.1,4 LEC is commonly 
diagnosed in patients between 40 and 70 years old.1 
Histologically, LEC consists of atypical epithelial-derived 
cells that have pale cytoplasm, prominent stroma, 
large-round vesicular nuclei, and prominent nucleoli. 
The tumor cells are surrounded by an extensive 
number of lymphocytes and plasma cells.5 There is 
no keratinization, necrosis, or mucus production.5 
Thus, syncytial sheets of large undifferentiated cells 
with vesicular nuclei intermingled with numerous 
nonneoplastic small lymphocytes and plasma cells 
characterize LEC histologically.2,3
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The EBV had been detected in 87.5% of all LEC 
cases.1,6 The role of EBV in the pathogenesis of LEC 
appears to be anatomical site-dependent.2,6 Tumors 
showing a similar histologic appearance have been 
described at different sites outside the nasopharynx. 
The EBV association has only been found in the 
salivary gland, lung, stomach, and thymus.2,6 Among 
the salivary glands, the parotid gland is most often 
affected. Moreover, in the head and neck region, 
LEC may also occur in the skin, oral cavity and 
nasopharynx.2 In the nasopharyngeal location, LEC 
frequently affects the tonsillar region and the base of 
the tongue. The palate, floor of the mouth, retromolar 
region, and buccal mucosa are among the affected 
oral sites.2,3,7 A systematic review gathered 30 LEC 
cases in the oral cavity and oropharynx (13 males and 
17 females). Thus, a slight male predominance (1.3:1) 
was observed, being the median age of 62 years 
(age range 11-80 years).1,2 To date, only two LEC cases 
affecting the lips have been reported.2,5
Treatment of LECs consists of surgery combined 
with radiotherapy and/or chemoradiation. Although 
local spread or nodal metastases are reasonably 
common at the time of diagnosis, the mortality rate 
of adequately treated LEC patients is low.1
Herein, we report the clinicopathological features 
of an EBV-negative LEC case affecting the lower lip of 
an old patient, with immunohistochemical and in situ 
hybridization analyses.
CASE REPORT
An 82-year-old white woman was referred to the 
Dental School, presenting an ulcerative lesion on her 
lower lip that has been developing over the last year. 
The nodular lesion presented an ulcerated surface, 
with flat edges, hardened base, painful, and absence 
of regional lymphadenopathy (Figure 1).
A n  i n c i s i o n a l  b i o p s y  w a s  p e r f o r m e d . 
The microscopical analysis evidenced an intense 
inflammatory infiltrate, composed of lymphoplasmacytic 
cells, associated with scarce pleomorphic epithelial cells. 
Immunohistochemistry highlighted the malignant cells, 
which showed strong expression of pan-cytokeratin 
(pan-CK) AE1/AE3, EMA, p63 and p53. CD138 was 
also faintly positive. Ki-67 labeling index was >85%. 
EBER oligonucleotide RNA in situ hybridization 
analysis did not show evidence of EBV infection 
(Figures 2, 3, and 4). The patient was submitted to 
Figure 1. Clinical view of the ulcerated lesion on the 
right side of the lower lip.
Figure 2. Photomicrographs of the lip biopsy showing: A – Tumor cells arranged in cords with a ribbon-like 
appearance admixed with intense lymphoplasmacytic inflammatory infiltrate; B – High magnification showing 
malignant epithelioid cells. (H&E stain, original magnification [A] x 20; [B] x40).
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Figure 3. Photomicrographs of the lip biopsy showing: A – pan-CK AE1/AE3 positivity highlighting the malignant 
cells; B – Malignant epithelial cells positive for EMA. Notice the positivity on plasma cells; C – Tumor cells exhibiting 
faint cell membrane staining positivity for CD138. Observe that the plasma cells are more strongly stained; 
D – Uniform positivity for p53 in LEC cells (A-D, immunohistochemistry, original magnification x20).
Figure 4. Photomicrographs of the lip biopsy showing: A – Strong p63 positivity highlighting the LEC cells; B – Most 
LEC cells positive for Ki-67 (>85%) (A-B, immunohistochemistry, original magnification x20). C – EBER oligonucleotide 
RNA in situ hybridization with uniform negativity (original magnification x40).
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W-plasty surgery, which also provided good functional 
and aesthetic results. The surgical specimen showed 
similar microscopical features, with negative surgical 
margins. After 2-year of follow-up, the patient is well, 
without recurrences.
DISCUSSION
The LEC is a distinctive subtype of poorly 
differentiated SCC or undifferentiated carcinoma 
that shares morphologic features with undifferentiated 
nasopharyngeal carcinoma, which often shows 
association with EBV infection.1-3 A similar association 
with EBV is emerging for LEC of the oral cavity, which 
appears to be strongly influenced by the patient’s 
ethnia.2 Noteworthy, LEC is rarely reported among 
the lip cancers.2,4,5 To the best of our knowledge, 
only two cases of EBV-negative LEC of the lower 
lip have been reported.2,5 The first case affected a 
73-year-old man,2 and the second case a 41-year-old 
man.5 In the first case, there were no palpable 
cervical lymph nodes, and an elliptical excision was 
performed. At 20 months’ follow-up, no signs of 
tumor recurrence were detected.2 In the second case, 
surgical resection and bilateral selective neck dissection 
(level I-II) were performed. TNM classification was 
T1N1M0 (stage III); therefore, chemoradiotherapy was 
indicated. At 3 years’ follow-up, the patient does not 
show evidence of disease.5 Taking into account this 
scarce sample, we dare conclude the LEC of the lips 
has a good prognosis.
A review of the literature, from 1980 to 2018, 
on the MEDLINE database, manual searches of 
bibliographic references, and cross-referencing was 
performed. Case reports and clinical series of oral, 
oropharyngeal, nasal, and paranasal sinus LECs were 
reviewed, gathering a total of 110 cases. Differently 
from LEC affecting the lips, the oral and oropharyngeal 
LECs have a greater tendency to metastasize (70%), 
and 16.6% spread locally, while the nasal and 
paranasal LECs rarely metastasize, but 60% spread 
locally.1
By microscopy, LEC exhibits syncytial sheets of 
large undifferentiated cells with vesicular nuclei and 
prominent nucleoli admixed with numerous reactive 
small lymphocytes and plasma cells.2,3 Sometimes, 
the neoplastic cells are challenging to visualize on 
microscopic examination, as observed in the current 
case. By immunohistochemistry, LEC shows strong 
positivity for CK in the epithelial component and 
CD45 in the lymphoplasmacytic infiltrate. Moreover, 
we observe positivity for EMA, p63, p53, and CD138, 
highlighting the malignant cells, whereas EMA and 
CD138 also evidenced the plasma cells.
The CD138 expression seems to correlate 
significantly with the histological differentiation grade, 
exhibiting weak and patchy immunostaining in poorly 
differentiated neoplasms.8,9 It is known that the cells 
from the deep invasive front are highly aggressive and 
less differentiated. In this context, reduced CD138 
expression was observed at the deep invasive front in 
oral SCC.8 Moreover, it seems to be that the CD138 
expression is reduced as lip carcinogenesis progresses.9 
Similarly, in the current case, different from CK and 
EMA, CD138 was faintly expressed.
Oral and oropharyngeal LECs have a high tendency 
to metastasize, mainly to regional lymph nodes, 
which substantially alter the prognosis.1,5,7 However, 
fortunately, these tumors are highly radiosensitive, 
with high rates of locoregional control.4 Accordingly, 
radiotherapy can be used as the primary treatment 
in head and neck LEC.5,7 However, a multimodality 
approach is generally recommended, where surgery 
must be the first choice, if possible, regardless of 
the localization, considering the clinical stage of the 
tumor.5 The higher survival rate for LEC of the oral 
cavity is documented. In this setting, it was reported 
a 94% local control rate in LEC of the head and neck 
region with radiotherapy. The 5-year overall survival 
and disease-specific survival were found as 39% 
and 59%, respectively.5,7 Despite this, literature data 
support the use of a combined modality approach. 
Adjuvant chemotherapy and/or radiotherapy should 
be considered when risk factors for recurrence are 
detected, including perineural invasion, lymphovascular 
invasion, positive lymph nodes, and positive surgical 
margins. Moreover, elective neck radiotherapy is 
recommended for patients with head and neck LEC.5
The lower lip LEC is a rare malignant neoplasm 
that should be included in the differential diagnosis 
of nodular ulcerative lesions affecting the lips. 
Immunohistochemistry and in situ hybridization 
analysis for EBV infection are important to establish 
the correct diagnosis. The treatment of choice for LEC 
is surgery, which can be associated with radiotherapy 
and/or chemotherapy. To the best of our knowledge, 
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we report the third EBV-negative LEC affecting the 
lower lip. These cases appear to present favorable 
prognosis; however, report of further cases is necessary 
to understand its clinicopathological features better.
REFERENCES
1. Rytkonen AE, Hirvikoski PP, Salo TA. Lymphoepithelial 
carcinoma: two case reports and a systematic review of oral 
and sinonasal cases. Head Neck Pathol. 2011;5(4):327-
34. http://dx.doi.org/10.1007/s12105-011-0278-7. 
PMid:21698444.
2. Mahomed F, Grayson W. A rare case of lymphoepithelial 
carcinoma of the lip. Oral Surg Oral Med Oral Pathol 
Oral Radiol Endod. 2008;105(5):e49-52. http://dx.doi.
org/10.1016/j.tripleo.2008.01.016. PMid:18442735.
3. Chow TL, Chow TK, Lui YH, Sze WM, Yuen NW, Kwok SP. 
Lymphoepithelioma-like carcinoma of oral cavity: report 
of three cases and literature review. Int J Oral Maxillofac 
Surg. 2002;31(2):212-8. http://dx.doi.org/10.1054/
ijom.2001.0148. PMid:12102423.
4. Bishop JA, Gaulard P, Gillison M. Lymphoepithelial 
carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, 
Takata T, Slootweg PJ. editors. WHO classification of 
Head and Neck Tumours. Lyon: IARC Press; 2017; p. 18.
5. Gultekin M, Sari SY, Gunhan O, et al. Lymphoepithelial 
carcinoma of the lower lip: report of a case. UHOD. 
2014;24(1):70-2. http://dx.doi.org/10.4999/uhod.12037.
6. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr 
virus in lymphoepithelioma-like carcinomas. Am J Clin 
Pathol. 1995;103(3):308-15. http://dx.doi.org/10.1093/
ajcp/103.3.308. PMid:7872253.
7. Dubey P, Ha CS, Ang KK, et al. Nonnasopharyngeal 
lymphoepithelioma of the head and neck. Cancer. 
1998;82(8):1556-62. http://dx.doi.org/10.1002/
(S IC I )1097-0142(19980415)82:8<1556: :A ID-
CNCR18>3.0.CO;2-3. PMid:9554534.
8. Kurokawa H, Zhang M, Matsumoto S, et al. Reduced 
syndecan-1 expression is correlated with the histological 
grade of malignancy at the deep invasive front in 
oral squamous cell carcinoma. J Oral Pathol Med. 
2006;35(5):301-6. http://dx.doi.org/10.1111/j.1600-
0714.2006.00412.x. PMid:16630294.
9. Martínez A, Spencer ML, Brethauer U, Grez P, Marchesani 
FJ, Rojas IG. Reduction of syndecan-1 expression during 
lip carcinogenesis. J Oral Pathol Med. 2009;38(7):580-3. 
http://dx.doi.org/10.1111/j.1600-0714.2009.00761.x. 
PMid:19473447.
Author contributions: Almeida LY, Bufalino A and de Paula JA contributed to the clinical and microscopic analyses 
and the review of the literature. Silveira HA, Silva EV and Barbeiro CO contributed with the immunohistochemical 
and in-situ hybridization reactions and manuscript writing. Ribeiro-Silva A and León JE, contributed to the 
manuscript design, final data analyses and critical review. All authors collectively proofread the final version 
and approved it for publication.
The authors retain informed consent and the manuscript is by the Institutional Ethics Committee.
Conflict of interest: None
Financial support: Luciana Yamamoto Almeida (2016/02713-2), Heitor Albergoni Silveira (2018/12734-2) 
and Jorge Esquiche León (2016/11419-0) have received research Grants from State of São Paulo Research 
Foundation (FAPESP).
Submitted on: October 11th, 2019
Accepted on: November 14th, 2019
Correspondence 
Jorge Esquiche León 
Patologia Oral - Departamento de Estomatologia - Saúde Coletiva e Odontologia Legal - Faculdade de 
Odontologia de Ribeirão Preto - Universidade de São Paulo (FORP/USP) 
Avenida do Café, s/n – Ribeirão Preto/SP – Brasil 
CEP: 14040-904 
Phone: +55 (16) 3315-4063/ +55 (16) 3315-4102. 
jleon@forp.usp.br
